Barry C. Lembersky

Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28

Eleftherios P. Mamounas, John Bryant, Barry C. Lembersky et al. · Journal of Clinical Oncology · 2005 · 714 citations

Medicine, Oncology, Pharmacology +17

Oral Uracil and Tegafur Plus Leucovorin Compared With Intravenous Fluorouracil and Leucovorin in Stage II and III Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project Protocol C-06

Barry C. Lembersky, H. Samuel Wieand, Nicholas J. Petrelli et al. · Journal of Clinical Oncology · 2006 · 326 citations · Full text

Medicine, Oncology, Surgery +15

Multicenter Phase III Study of Uracil/Tegafur and Oral Leucovorin Versus Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer

Jean‐Yves Douillard, Paulo M. Hoff, Jamey Skillings et al. · Journal of Clinical Oncology · 2002 · 323 citations

Medicine, Oncology, Pharmacology +14

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial

Alexander Paterson, Stewart Anderson, Barry C. Lembersky et al. · The Lancet Oncology · 2012 · 194 citations · Full text

Medicine, Oncology, Pharmacology +11

Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer

Brian A. Boone, Jennifer Steve, Alyssa M. Krasinskas et al. · Journal of Surgical Oncology · 2013 · 193 citations · Full text

Medicine, Oncology, Surgery +15